Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

Clinical trial NCT07367516 · RECRUITING

Trial details

NCT number: NCT07367516
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2026-02-12
Primary completion: 2026-09-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.